Validity of Montreal Cognitive Assessment in Non-English speaking patients with Parkinson's disease

dc.contributor.authorKrishnan, S
dc.contributor.authorJustus, S
dc.contributor.authorMeluveettil, R
dc.contributor.authorMenon, RN
dc.contributor.authorSarma, SP
dc.contributor.authorKishore, A
dc.date.accessioned2017-03-10T03:29:13Z
dc.date.available2017-03-10T03:29:13Z
dc.date.issued2015
dc.description.abstractBackground: The Montreal Cognitive Assessment is a brief and easy screening tool for accurately testing cognitive dysfunction in Parkinson's disease. We tested its validity for use in non-English (Malayalam) speaking patients with Parkinson's disease. Materials and Methods: We developed a Malayalam (a south-Indian language) version of Montreal Cognitive Assessment and applied to 70 patients with Parkinson's disease and 60 age-and education-matched healthy controls. Metric properties were assessed, and the scores were compared with the performance in validated Malayalam versions of Mini Mental Status Examination and Addenbrooke's Cognitive Examination. Results: The Montreal Cognitive Assessment-Malayalam showed good internal consistency and test-retest reliability and its scores correlated with Mini Mental Status Examination (patients: R = 0.70; P < 0.001; healthy controls: R = 0.26; P = 0.04) and Addenbrooke's Cognitive Examination (patients: R = 0.8; P < 0.001; healthy controls: R = 0.52; P < 0.001) scores. Conclusion: This study establishes the reliability of cross-cultural adaptation of Montreal Cognitive Assessment for assessing cognition in Malayalam-speaking Parkinson's disease patients for early screening and potential future interventions for cognitive dysfunction.
dc.identifier.citation63 ,1;63-67en_US
dc.identifier.uri10.4103/0028-3886.152637
dc.identifier.urihttps://dspace.sctimst.ac.in/handle/123456789/10675
dc.publisherNEUROLOGY INDIA
dc.subjectNeurosciences & Neurology
dc.titleValidity of Montreal Cognitive Assessment in Non-English speaking patients with Parkinson's disease
Files
Collections